These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serum glutamic oxalacetic transaminase/glutamic pyruvic transaminase ratios in hepatocellular carcinoma. Shimokawa Y, Okuda K, Kubo Y, Kaneko A, Arishima T, Nagata E, Hashimoto M, Sawa Y, Nagasaki Y, Kojiro M, Sakamoto K, Nakashima T. Cancer; 1977 Jul; 40(1):319-24. PubMed ID: 195707 [Abstract] [Full Text] [Related]
8. The mechanism of the release of hepatic enzymes in various liver diseases. 1. Alterations in cytoplasmic and mitochondrial enzyme activities in serum. Miyake S. Acta Med Okayama; 1979 Aug; 33(4):287-304. PubMed ID: 227231 [Abstract] [Full Text] [Related]
11. The relationship between hepatitis-associated antigen and the development of hepatocellular cancer. Theodoropoulos G, Economopoulos P, Mitakos S, Angelopoulos Ba. Acta Hepatogastroenterol (Stuttg); 1974 Dec; 21(6):430-2. PubMed ID: 4377058 [No Abstract] [Full Text] [Related]
12. N-acetylglucosaminyltransferase III in human serum, and liver and hepatoma tissues: increased activity in liver cirrhosis and hepatoma patients. Ishibashi K, Nishikawa A, Hayashi N, Kasahara A, Sato N, Fujii S, Kamada T, Taniguchi N. Clin Chim Acta; 1989 Dec 15; 185(3):325-32. PubMed ID: 2482796 [Abstract] [Full Text] [Related]
15. Proceedings: Primary liver cancer. A review of the clinical features, blood groups, serum enzymes, therapy, and survival of 65 cases. al-Sarraf M, Go TS, Kithier K, Vaitkevicius VK. Cancer; 1974 Feb 15; 33(2):574-82. PubMed ID: 4360057 [No Abstract] [Full Text] [Related]
16. [Enzymatic parameters in diagnosis of fatty liver ]. Nilius R, Peters JE, Farr W, Gründig CA, Otto L, Busse HJ, Zipprich B, Eismann R, Mantel E. Z Gesamte Inn Med; 1973 Sep 01; 28(17):268-70 passim. PubMed ID: 4148891 [No Abstract] [Full Text] [Related]